Delivery Order SPE2DB22D3301-SPE2DB25FZ1ET
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (30-count units) valued at $1,464.52 under a firm fixed-price contract. The delivery order, issued on September 26, 2025, requires completion by September 29, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded, reflecting the contractor's capability to meet federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,017.90 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count). This competitively awarded, firm fixed-price contract was finalized on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count) with a ceiling value of $2,481.37. The award, issued on November 17, 2025, represents a firm fixed-price delivery order with an ultimate completion date of November 18, 2025. This contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units, with a ceiling value of $3,320.50. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a typical transactional delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCl 250 mg tablets in a 30-count configuration, with a contract ceiling value of $24,344.33. This is a firm fixed-price delivery order issued on September 29, 2025, with an ultimate completion date of September 30, 2025. The award carries no set-aside designation, indicating it was competitively awarded through open procurement. AmerisourceBergen Drug Corp, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Terbinafine HCL 250 mg tablets (90-count units) on November 17, 2025, with a ceiling value of $1,110.08 and a firm fixed price structure. This is a non-set-aside competitive award issued as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Terbinafine HCL 250 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $3,169.62 and an ultimate completion date of September 29, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. The order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,706.98 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (30-count units). The contract was awarded on December 3, 2025, with an ultimate completion date of December 4, 2025, under a firm fixed-price arrangement with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,784.72 to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets (90-count) on November 24, 2025, with an ultimate completion date of November 25, 2025. This is a firm fixed price, non-set-aside contract with performance conducted at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at approximately $39,194 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Terbinafine HCl 250 mg tablets in quantities of 100 units. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 27, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FZ1ETDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Terbinafine HCL 250 mg tablets in quantities of 90 units, with a contract value of $1,559.63. The award, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, is structured as a firm fixed-price delivery order without set-aside designation. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a broad range of generic and brand-name medications, vaccines, and medical devices to support military and veteran healthcare systems. The competitive award reflects the contractor's demonstrated capability to fulfill federal pharmaceutical requirements through open competition and its established role within DLA's Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/18/25 |